AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
Jul 7, 2025
35599_dirs_2025-07-07_09ee2775-36fc-47ae-8ced-9662ae14b3b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-07-07
Reporting Person: RALLIS CHRIS A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-07 | Common Shares | M | 2127 | $2.35 | Acquired | 55911 | Direct |
| 2025-07-07 | Common Shares | S | 1119 | $8.71 | Disposed | 54792 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-07 | Common Shares | $2.35 | M | 2127 | Disposed | 2025-08-03 | Options (2127) | Direct |
Footnotes
F1: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
F2: Shares sold to satisfy tax obligation on option exercise.
F3: Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20